Armstrong Advisory Group, Inc Amneal Pharmaceuticals, Inc. Transaction History
Armstrong Advisory Group, Inc
- $1.22 Billion
- Q2 2025
A detailed history of Armstrong Advisory Group, Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Armstrong Advisory Group, Inc holds 150 shares of AMRX stock, worth $1,261. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150Holding current value
$1,261% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
245Shares Held
136MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA15.8MShares$133 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$104 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$94.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$90.3 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$63 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.27B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...